Immediate Allergic Hypersensitivity to Quinolones Associates with Neuromuscular Blocking Agent Sensitization

Journal of Allergy and Clinical Immunology: In Practice

Volumn 1, Issue 3, 2013, Pages

  Rouzaire, Paul ^a,b,c,f   Nosbaum, Audrey ^a,b,c   Mullet, Christine ^d   Diot, Nathalie ^d   Dubost, Rolande ^d   Bienvenu, Françoise ^a   Guilloux, Laurence ^e   Piriou, Vincent ^d   Bienvenu, Jacques ^a,b,c   Bérard, Frédéric ^a,b,c  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b INSERM   (France)

^c UNIVERSITÉ LYON 1   (France)

^d HOSPICES CIVILS DE LYON   (France)

^e Biomnis Laboratory   (France)

^f UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

Cross reactivity; Drug allergy; Drug immediate hypersensitivity; Neuromuscular blocking agent; Quaternary ammonium ions; Quinolones; Sensitization

Indexed keywords

ATRACURIUM BESILATE; CISATRACURIUM; IMMUNOGLOBULIN E; LEVOFLOXACIN; LOMEFLOXACIN; MIVACURIUM; MOXIFLOXACIN; NEUROMUSCULAR BLOCKING AGENT; NORFLOXACIN; OFLOXACIN; PANCURONIUM; PIPEMIDIC ACID; PLACEBO; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ROCURONIUM; SUXAMETHONIUM; VECURONIUM;

ADULT; ANTIBODY DETECTION; ARTICLE; BASOPHIL; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL HISTORY; PREVALENCE; PRICK TEST; PROVOCATION TEST; SKIN TEST;

CROSS-REACTIVITY; DRUG ALLERGY; DRUG IMMEDIATE HYPERSENSITIVITY; NEUROMUSCULAR BLOCKING AGENT; QUATERNARY AMMONIUM IONS; QUINOLONES; SENSITIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BASOPHILS; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKING AGENTS; PROSPECTIVE STUDIES; QUINOLONES;

EID: 84877070074     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2013.02.007     Document Type: Article

References (20)

1. Andriole V.T. The quinolones: past, present, and future. Clin Infect Dis 2005, 15:S113-S119.
2. Campi P., Pichler W.J. Quinolone hypersensitivity. Curr Opin Allergy Clin Immunol 2003, 3:275-281.
3. Manfredi M., Severino M., Testi S., Macchia D., Ermini G., Pichler W.J., et al. Detection of specific IgE to quinolones. J Allergy Clin Immunol 2004, 113:155-160.
4. Aranda A., Mayorga C., Ariza A., Dona I., Rosado A., Blanca-Lopez N., et al. In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones. Allergy 2011, 66:247-254.
5. Rouzaire P., Nosbaum A., Denis L., Bienvenu F., Berard F., Cozon G., et al. Negativity of the basophil activation test in quinolone hypersensitivity: a breakthrough for provocation test decision-making. Int Arch Allergy Immunol 2012, 157:299-302.
6. Studer M., Brusztejn A.C., Waton J., Gastin I., Cuny J.F., Schmutz J.L., et al. La polysensibilisation médicamenteuse systémique existe-t-elle?. Ann Dermatol Ven 2009, 136:A36-A50.
7. Baldo B.A., Fisher M.M. Substituted ammonium ions as allergenic determinants in drug allergy. Nature 1983, 306:262-264.
8. Simons F.E. Anaphylaxis. J Allergy Clin Immunol 2010, 125:S161-S181.
9. Ring J., Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977, 1:466-469.
10. Mertes P.M., Malinovsky J.M., Jouffroy L., Aberer W., Terreehorst I., Brockow K., et al. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. J Investig Allergol Clin Immunol 2011, 21:442-453.
11. Rouzaire P., Proton G., Bienvenu F., Guilloux L., Benoit Y., Piriou V., et al. IgE antibody detection in the diagnosis of hypersensitivity to neuromuscular blocking agents. Acta Anaesthesiol Scand 2012, 56:263-264.
12. Ebo D.G., Venemalm L., Bridts C.H., Degerbeck F., Hagberg H., De Clerck L.S., et al. Immunoglobulin E antibodies to rocuronium: a new diagnostic tool. Anesthesiology 2007, 107:253-259.
13. Ramirez L.F., Pereira A., Chiriac A.M., Bonnet-Boyer M.C., Demoly P. Negative predictive value of skin tests to neuromuscular blocking agents. Allergy 2012, 67:439-441.
14. Fisher M.M., Munro I. Life-threatening anaphylactoid reactions to muscle relaxants. Anesth Analg 1983, 62:559-564.
15. Baldo B.A., Fisher M.M., Pham N.H. On the origin and specificity of antibodies to neuromuscular blocking (muscle relaxant) drugs: an immunochemical perspective. Clin Exp Allergy 2009, 39:325-344.
16. Florvaag E., Johansson S.G., Oman H., Venemalm L., Degerbeck F., Dybendal T., et al. Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively. Acta Anaesthesiol Scand 2005, 49:437-444.
17. Florvaag E., Johansson S.G., Irgens A., de Pater G.H. IgE-sensitization to the cough suppressant pholcodine and the effects of its withdrawal from the Norwegian market. Allergy 2011, 66:955-960.
18. Johansson S.G., Florvaag E., Oman H., Poulsen L.K., Mertes P.M., Harper N.J., et al. National pholcodine consumption and prevalence of IgE-sensitization: a multicentre study. Allergy 2010, 65:498-502.
19. Sachs B., Riegel S., Seebeck J., Beier R., Schichler D., Barger A., et al. Fluoroquinolone-associated anaphylaxis in spontaneous adverse drug reaction reports in Germany: differences in reporting rates between individual fluoroquinolones and occurrence after first-ever use. Drug Saf 2006, 29:1087-1100.
20. Baeck M., Chemelle J.A., Goossens A., Nicolas J.F., Terreux R. Corticosteroid cross-reactivity: clinical and molecular modelling tools. Allergy 2011, 66:1367-1374.